Randomized controlled trials in inflammatory bowel diseases: The case for the positive control
β Scribed by Dr. A. Hillary Steinhart
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 501 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background: The use of complementary and alternative medicine in inflammatory bowel disease (IBD) has been extensively studied. However, the use of probiotics and prebiotics is poorly documented, despite evidence of efficacy of particular probiotic strains in specific forms of IBD. ## Methods: A
## Background: The incidence of inflammatory bowel disease (IBD) is increasing among adolescents. In all, 25% of patients are diagnosed before the age of 16, when they are traditionally transferred from the pediatric to the adult service. ## Methods: We conducted a retrospective case-controlled s
## Background: Inherited risk factors have been suggested to play an important role in the pathogenesis of vascular complications of inflammatory bowel disease (ibd). the aim of the present study was to investigate the role of mutations associated with cardiovascular disease in ibd patients with or
The risk for gallstones (GD) in inflammatory bowel diseases and the factors responsible for this complication have not been well established. We studied the incidence of GD in a cohort of Crohn's disease (CD) and ulcerative colitis (UC) patients and investigated the related risk factors. A case-cont